PEGylated Polyethylenimine as Enhanced T1 Contrast Agent for Efficient Magnetic Resonance Imaging

Shengyuan Zhou, Zhenkai Wu, Xiongsheng Chen, Lianshun Jia, Wei ZhuACS 2014 · DOI

Abstract

Currently used small molecular magnetic resonance (MR) imaging contrast agents (CAs) in clinics have relatively short half-lives, which has limited the acquisition of high-resolution organ and angiographic images. Therefore, development of a facile strategy for the synthesis of long-circulating CAs with the transforming potential for MR imaging still remains a great challenge. Here we communicate the design and synthesis of PEGylated polyethylenimine (PEI) and its application as enhanced T1 CA for the long-circulating blood pool as well as efficient organ and tumor imaging. In this study, PEI was covalently grafted with gadolinium (Gd(III)) chelator and mPEG-NHS, followed by acetylation of the remaining amines to improve biocompatibility and prolong circulation time. With the relatively long circulation time (3.8 h), the formed multifunctional PEI (PEI.NHAc-DTPA(Gd(III))-mPEG) can be used as an enhanced T1 CA for blood pool and major organ imaging, and could be cleared from the body 96 h post administration through the urinary system. Importantly, the PEI.NHAc-DTPA(Gd(III))-mPEG complexes displayed a strong T1 contrast effect for tumor imaging through the enhanced permeation and retention effect. These findings suggest that the synthesized PEI.NHAc-DTPA(Gd(III))-mPEG may be used as a promising CA for T1 MR imaging of various biological systems.
BibTeX
@inproceedings{zhou2014pegylated,
  author = {Shengyuan Zhou and Zhenkai Wu and Xiongsheng Chen and Lianshun Jia and Wei Zhu},
  title = {{PEGylated Polyethylenimine as Enhanced T<sub>1</sub> Contrast Agent for Efficient Magnetic Resonance Imaging}},
  booktitle = {ACS},
  year = {2014},
  doi = {10.1021/am5020875},
}

Loading related content...

Figure